Antibiotics used maternally for preterm birth had mixed effects on outcomes in children 7 years later.
Preterm birth is a major cause of neonatal morbidity and mortality worldwide. The mechanisms of preterm birth are complex, but infection and inflammation often are involved. Therefore, antibiotics have been used to improve neonatal outcomes. Now, investigators report outcomes in 7-year-old children whose mothers participated in the ORACLE clinical trials of antibiotics for preterm births.
Investigators in ORACLE I randomized women with preterm rupture of membranes but no clinical signs of infection to receive erythromycin, amoxicillin-clavulanate, both antibiotics, or placebo. At delivery, women who received erythromycin were less likely than women in the other groups to have infants with poor outcomes (death, major cerebral abnormality, or …
Reviewing Author
DisclosuresConsultant/Advisory BoardAicuris; Bayer; GSK; Innovative Molecules; Merck; MAPP Biopharmaceutical (Safety Monitoring Committee)
RoyaltiesUpToDate
Grant/Research SupportNIH/National Institute of Allergy and Infectious Diseases; GSK; Moderna; Assembly Biomedical; Aicuris
Editorial BoardsSexually Transmitted Diseases; Sexually Transmitted Infections; Journal of Infectious Diseases
Leadership PositionsID Division Chiefs Community of Practice (At-Large Member)
DisclosuresConsultant/Advisory BoardAicuris; Bayer; GSK; Innovative Molecules; Merck; MAPP Biopharmaceutical (Safety Monitoring Committee)
RoyaltiesUpToDate
Grant/Research SupportNIH/National Institute of Allergy and Infectious Diseases; GSK; Moderna; Assembly Biomedical; Aicuris
Editorial BoardsSexually Transmitted Diseases; Sexually Transmitted Infections; Journal of Infectious Diseases
Leadership PositionsID Division Chiefs Community of Practice (At-Large Member)